Skip to content



ECOSYSTEM - Full Scale Industry


Israeli companies are rooted in top international academic and research institutions; staffed by highly educated and skilled teams; operating within an entrepreneurial and audacious climate, to offer a variety of


logo Syneron logo alma logo lumenis
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Syneron Medical manufactures and markets medical aesthetic equipment. The company was founded in 2000 in 2004 it was issued for the first time at a value of $330M. At the beginning, the company worked mainly in laser hair removal, and in 2010 it acquired the American competitor Candela and was renamed Syneron Candela.

Alma Lasers, founded in 1999, manufactures and markets products for the purpose of aesthetic treatment in a non-invasive manner. In 2013, the company was acquired by Fosun Pharma at a value of $240M, and was renamed Sisram Laser.

Lumenis, established and operating in Israel, is considered to be the leader of the global medical laser market. The company manufactures and markets laser equipment for almost every medical procedure including the first treatment line for some cancerous tumors.


INNOVATIVE RESEARCH   Percentage of Scientific Publications in Israel
logo tel aviv university   logo barilan

Professor Natan Shaked of the Department of Biomedical Engineering at Tel Aviv University is currently leading an innovative idea that will enable an improvement in the ability to select sperm cells suitable for fertilizing the egg. The development is based on the screening of sperm cells by weak laser beams that enable the creation of a digital diagram that can be processed and analyzed. The method provides extensive information about the sperm cells in vitro without damaging their structure and function.


An example of outstanding academic progress is the optophone optoelectronic system, developed by Prof. Zeev Zalevsky and Yevgeny Biederman of Bar-Ilan University in cooperation with a Spanish colleague. This is a tiny laser-based device beamed on the skin that can receive subcutaneous signals that provide information about clinical parameters of the patient without the need for using a needle and taking blood samples. Its business potential is estimated in hundreds of millions of dollars.

RECOGNIZING POTENTIAL   Governmental Grants to Life Sciences Companies in Israel